Oral milk exosome-PLGA nanoparticles enhance anti-tuberculosis efficacy of PBTZ169 and bedaquiline
Authors:
- Eryue LiuELEryue Liu
- Chennan LiuCLChennan Liu
- Yangxue YeYYYangxue Ye
- Zimo WangZWZimo Wang
- Weiyan ZhangWZWeiyan Zhang
- Lei FuLFLei Fu
- Bin WangBWBin Wang
- Yujin WangYWYujin Wang
- Yu LuYLYu Lu
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82173862)
- Chinese Academy of Medical Sciences
- Beijing Municipal Administration of Hospitals (DFL20221402)
This publication has 46 references indexed in Scilit:
- Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailabilityActa Pharmacologica Sinica, 2016
- Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cellsNanomedicine: Nanotechnology, Biology and Medicine, 2016
- Bovine milk-derived exosomes for drug deliveryCancer Letters, 2016
- Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Therapeutic Advances in Chronic Disease, 2015
- Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccinesDrug Delivery, 2014
- Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis DrugAntimicrobial Agents and Chemotherapy, 2014
- Towards a new combination therapy for tuberculosis with next generation benzothiazinonesEMBO Molecular Medicine, 2014
- PLGA-based nanoparticles: An overview of biomedical applicationsJournal of Controlled Release, 2012
- How Autocatalysis Accelerates Drug Release from PLGA-Based Microparticles: A Quantitative TreatmentBiomacromolecules, 2005
- Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosisJournal of Antimicrobial Chemotherapy, 2004